phosphorus-radioisotopes and Pelvic-Inflammatory-Disease

phosphorus-radioisotopes has been researched along with Pelvic-Inflammatory-Disease* in 1 studies

Other Studies

1 other study(ies) available for phosphorus-radioisotopes and Pelvic-Inflammatory-Disease

Article	Year
Adjuvant intraperitoneal chromic phosphate therapy in a woman with early ovarian carcinoma and pelvic infection with resulting catastrophic complications. Clinical nuclear medicine, 1994, Volume: 19, Issue:8 Women diagnosed with early stage ovarian cancer may be considered for adjuvant therapy. Intraperitoneal chromic phosphate (P-32) is commonly used in these patients with few complications. A woman found to have early stage ovarian cancer was given intraperitoneal P-32 in the presence of a lingering pelvic infection, which is usually not mentioned as a contraindication to its use. Radiation damage to the small bowel and cecum developed as did damage to the ureter and bladder, which then required surgery. Topics: Adult; Chromium Compounds; Contraindications; Cystadenoma, Mucinous; Female; Humans; Hysterectomy; Instillation, Drug; Ovarian Neoplasms; Pelvic Inflammatory Disease; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiation Injuries; Radiotherapy, Adjuvant	1994

Article

Year

Adjuvant intraperitoneal chromic phosphate therapy in a woman with early ovarian carcinoma and pelvic infection with resulting catastrophic complications.

Clinical nuclear medicine, 1994, Volume: 19, Issue:8

Women diagnosed with early stage ovarian cancer may be considered for adjuvant therapy. Intraperitoneal chromic phosphate (P-32) is commonly used in these patients with few complications. A woman found to have early stage ovarian cancer was given intraperitoneal P-32 in the presence of a lingering pelvic infection, which is usually not mentioned as a contraindication to its use. Radiation damage to the small bowel and cecum developed as did damage to the ureter and bladder, which then required surgery.

Topics: Adult; Chromium Compounds; Contraindications; Cystadenoma, Mucinous; Female; Humans; Hysterectomy; Instillation, Drug; Ovarian Neoplasms; Pelvic Inflammatory Disease; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiation Injuries; Radiotherapy, Adjuvant

1994